SCHEMBL7399345

SCHEMBL7399345

Cc1cc(-c2cnccn2)ccc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.44
CYP19A1 P11511 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
PIK3CD O00329 1/20 0.43
PIK3CA P42336 1/20 0.43
PIK3CB P42338 1/20 0.43
PI4KA P42356 1/20 0.43
PIK3CG P48736 1/20 0.43
PI4KB Q9UBF8 1/20 0.43
CHEK1 O14757 1/20 0.43
PIM2 Q9P1W9 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
PIM1 P11309 1/20 0.40
DAPK3 O43293 1/20 0.40
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2406176 0.84 NPC1 (0.49) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL15262305 0.80 CYP2D6 (0.40) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL22053021 0.79 ALOX5AP (0.45) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL16385300 0.79 HSD17B1 (0.47) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL2409087 0.79 PIM1 (0.46) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL24732450 0.77 CYP2D6 (0.49) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL16385234 0.77 RAB9A (0.53) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL25480188 0.77 CYP2D6 (0.45) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL8798053 0.76 PIM2 (0.39) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD
SCHEMBL2559473 0.76 KMO (0.49) CYP2D6CYP19A1CYP2C9CYP2C19PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799226-B1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2001-02-07 EP disclosed
US-5972951-A Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists SMITHKLINE BEECHAM PLC (GB) 1999-10-26 US disclosed
US-5801170-A Heterocyclic biphenylylamides useful as 5HT1D antagonists SMITHKLINE BEECHAM PLC (GB) 1998-09-01 US disclosed
EP-0799226-A1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-10-08 EP disclosed
EP-0733048-A1 HETEROCYCLIC BIPHENYLYLAMIDES USEFUL AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-09-25 EP disclosed
WO-1996019477-A1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-06-27 WO disclosed
WO-1995015954-A1 HETEROCYCLIC BIPHENYLYLAMIDES USEFUL AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-06-15 WO disclosed